Skip to main content

Advertisement

Table 1 Patient, tumor and treatment characteristics with univariate analysis

From: Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients

Variable Number (%) P Value
Age (years)   
  Median 55 0.0008
  Range 30-89  
Sex   
  Male 83 (83) >0.999
  Female 17 (17)  
Performance Status (ECOG)   
  Normal 66 (66) >0.999
  Inhibited (> = 1) 34 (34)  
Body-Mass-Index (BMI), pretreatment   
  Median 28.1 0.152
Smoking   
  None 37 (37) 0.536
  <20 pack years 26 (26)  
  20 - 40 pack years 25 (25)  
  >40 pack years 12 (12)  
Tumor Site   
  Oral Cavity 4 (4) 0.094
  Oropharynx 58 (58)  
  Hypopharynx 3 (3)  
  Nasopharynx 9 (9)  
  Larynx 13 (13)  
  Unknown primary 13 (13)  
T stage (AJCC 7th edition)   
  T0-T2 75 (75) 0.185
  T3-T4 25 (25)  
N stage (AJCC 7th edition)   
  N0-N1 24 (24) 0.184
  N2-N3 76 (76)  
Group stage (AJCC 7th edition)   
  III 18 (18) 0.165
  IV (locoregional) 72 (72)  
Chemotherapy   
  Cisplatin 63 (63) 0.114
  DFH (Docetaxel/5-FU/Hydroxyurea) 23 (23) 0.042
  Cetuximab or other 11 (11) >0.999
  None 3 (3)  
Induction?   
  Yes 17 (17) >0.999
  No 83 (83)  
BID treatment?   
  Yes 21 (21) 0.040
  No 79 (79)  
Modality   
  Definitive 77 (77) 0.614
  Adjuvant 23 (23)  
  1. Abbreviations: AJCC = American Joint Committee on Cancer, ECOG = Eastern Cooperative Oncology Group.